Other
Raw materials
Moderna Raw materials decreased by 10.0% to $27M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.6%, from $28M to $27M. Over 5 years (FY 2020 to FY 2025), Raw materials shows a downward trend with a -17.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2020
Last reportedQ1 2026May 1, 2026
Metric ID:
other_raw_materials_accounts_payableHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $184M | $141M | $260M | $228M | $317M | $246M | $316M | $58M | $62M | $71M | $27M | $36M | $42M | $57M | $41M | $28M | $30M | $46M | $30M | $27M |
| QoQ Change | — | -23.4% | +84.4% | -12.3% | +39.0% | -22.4% | +28.5% | -81.6% | +6.9% | +14.5% | -62.0% | +33.3% | +16.7% | +35.7% | -28.1% | -31.7% | +7.1% | +53.3% | -34.8% | -10.0% |
| YoY Change | — | — | — | — | +72.3% | +74.5% | +21.5% | -74.6% | -80.4% | -71.1% | -91.5% | -37.9% | -32.3% | -19.7% | +51.9% | -22.2% | -28.6% | -19.3% | -26.8% | -3.6% |
Range$27M – $317M
CAGR-33.2%
Avg YoY Growth-18.0%
Median YoY Growth-24.5%
Current Streak2 quarters decline
Frequently Asked Questions
- What is Moderna's raw materials?
- Moderna (MRNA) reported raw materials of $27M in Q1 2026.
- How has Moderna's raw materials changed year-over-year?
- Moderna's raw materials decreased by 3.6% year-over-year, from $28M to $27M.
- What is the long-term trend for Moderna's raw materials?
- Over 5 years (2020 to 2025), Moderna's raw materials has grown at a -17.4% compound annual growth rate (CAGR), from $78M to $30M.